| North Buncombe Family Medicine, P.a. | |
|
201 Flat Creek Village Dr. Weaverville NC 28787 | |
| (828) 645-8525 | |
| (828) 645-8935 |
| Full Name | North Buncombe Family Medicine, P.a. |
|---|---|
| Speciality | Family Medicine |
| Location | 201 Flat Creek Village Dr., Weaverville, North Carolina |
| Authorized Official Name and Position | Robert Brian Moore (PRESIDENT) |
| Authorized Official Contact | 8286458525 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| North Buncombe Family Medicine, P.a. 201 Flat Creek Village Dr. Weaverville NC 28787 Ph: (828) 645-8525 | North Buncombe Family Medicine, P.a. 201 Flat Creek Village Dr. Weaverville NC 28787 Ph: (828) 645-8525 |
| NPI Number | 1033149315 |
|---|---|
| Provider Enumeration Date | 07/03/2006 |
| Last Update Date | 08/24/2023 |
| Medicare PECOS PAC ID | 2466455977 |
|---|---|
| Medicare Enrollment ID | O20060822000408 |
News Archive
It doesn't take a political genius to see where the contest between President Obama and Mitt Romney is heading. With Rep. Paul Ryan on the Republican ticket, the campaign is looking at a full-throated debate over the future of Medicare. Are Romney and Ryan ready?
The world's most important scientific congress on the menopause will take place in Cancun, Mexico from 1-4 May 2014. Up to 3000 delegates are expected to attend.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.
A team of researchers from the US and UK used the AGM intranasal model of SARS-CoV-2 infection to determine differences between a contemporary SARS-CoV-2 D614G variant circulating in summer 2020 and the B.1.1.7 UK variant of concern that emerged in late 2020.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033149315 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 363LF0000X | Nurse Practitioner - Family | (* (Not Available)) | Secondary |
| Provider Name | Robert B Moore |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1952362659 PECOS PAC ID: 1153364815 Enrollment ID: I20050603000920 |
News Archive
It doesn't take a political genius to see where the contest between President Obama and Mitt Romney is heading. With Rep. Paul Ryan on the Republican ticket, the campaign is looking at a full-throated debate over the future of Medicare. Are Romney and Ryan ready?
The world's most important scientific congress on the menopause will take place in Cancun, Mexico from 1-4 May 2014. Up to 3000 delegates are expected to attend.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.
A team of researchers from the US and UK used the AGM intranasal model of SARS-CoV-2 infection to determine differences between a contemporary SARS-CoV-2 D614G variant circulating in summer 2020 and the B.1.1.7 UK variant of concern that emerged in late 2020.
› Verified 7 days ago
| Provider Name | Henry C Mcdade |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1912947581 PECOS PAC ID: 1456354976 Enrollment ID: I20060829000143 |
News Archive
It doesn't take a political genius to see where the contest between President Obama and Mitt Romney is heading. With Rep. Paul Ryan on the Republican ticket, the campaign is looking at a full-throated debate over the future of Medicare. Are Romney and Ryan ready?
The world's most important scientific congress on the menopause will take place in Cancun, Mexico from 1-4 May 2014. Up to 3000 delegates are expected to attend.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.
A team of researchers from the US and UK used the AGM intranasal model of SARS-CoV-2 infection to determine differences between a contemporary SARS-CoV-2 D614G variant circulating in summer 2020 and the B.1.1.7 UK variant of concern that emerged in late 2020.
› Verified 7 days ago
| Provider Name | Jennifer J Hall |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1639125859 PECOS PAC ID: 8628138781 Enrollment ID: I20090115000356 |
News Archive
It doesn't take a political genius to see where the contest between President Obama and Mitt Romney is heading. With Rep. Paul Ryan on the Republican ticket, the campaign is looking at a full-throated debate over the future of Medicare. Are Romney and Ryan ready?
The world's most important scientific congress on the menopause will take place in Cancun, Mexico from 1-4 May 2014. Up to 3000 delegates are expected to attend.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.
A team of researchers from the US and UK used the AGM intranasal model of SARS-CoV-2 infection to determine differences between a contemporary SARS-CoV-2 D614G variant circulating in summer 2020 and the B.1.1.7 UK variant of concern that emerged in late 2020.
› Verified 7 days ago
| Provider Name | Tami Wessels Swift |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487814091 PECOS PAC ID: 4880918903 Enrollment ID: I20150121000751 |
News Archive
It doesn't take a political genius to see where the contest between President Obama and Mitt Romney is heading. With Rep. Paul Ryan on the Republican ticket, the campaign is looking at a full-throated debate over the future of Medicare. Are Romney and Ryan ready?
The world's most important scientific congress on the menopause will take place in Cancun, Mexico from 1-4 May 2014. Up to 3000 delegates are expected to attend.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.
A team of researchers from the US and UK used the AGM intranasal model of SARS-CoV-2 infection to determine differences between a contemporary SARS-CoV-2 D614G variant circulating in summer 2020 and the B.1.1.7 UK variant of concern that emerged in late 2020.
› Verified 7 days ago
| Provider Name | Jessica Elizabeth Anewalt |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1851651897 PECOS PAC ID: 0648429274 Enrollment ID: I20150722005737 |
News Archive
It doesn't take a political genius to see where the contest between President Obama and Mitt Romney is heading. With Rep. Paul Ryan on the Republican ticket, the campaign is looking at a full-throated debate over the future of Medicare. Are Romney and Ryan ready?
The world's most important scientific congress on the menopause will take place in Cancun, Mexico from 1-4 May 2014. Up to 3000 delegates are expected to attend.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.
A team of researchers from the US and UK used the AGM intranasal model of SARS-CoV-2 infection to determine differences between a contemporary SARS-CoV-2 D614G variant circulating in summer 2020 and the B.1.1.7 UK variant of concern that emerged in late 2020.
› Verified 7 days ago
| Provider Name | Katelynn S Graeme |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1215321393 PECOS PAC ID: 4688964075 Enrollment ID: I20191023002080 |
News Archive
It doesn't take a political genius to see where the contest between President Obama and Mitt Romney is heading. With Rep. Paul Ryan on the Republican ticket, the campaign is looking at a full-throated debate over the future of Medicare. Are Romney and Ryan ready?
The world's most important scientific congress on the menopause will take place in Cancun, Mexico from 1-4 May 2014. Up to 3000 delegates are expected to attend.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.
A team of researchers from the US and UK used the AGM intranasal model of SARS-CoV-2 infection to determine differences between a contemporary SARS-CoV-2 D614G variant circulating in summer 2020 and the B.1.1.7 UK variant of concern that emerged in late 2020.
› Verified 7 days ago
| Provider Name | Joshua Alan Christian |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1629574132 PECOS PAC ID: 1153726708 Enrollment ID: I20210820000719 |
News Archive
It doesn't take a political genius to see where the contest between President Obama and Mitt Romney is heading. With Rep. Paul Ryan on the Republican ticket, the campaign is looking at a full-throated debate over the future of Medicare. Are Romney and Ryan ready?
The world's most important scientific congress on the menopause will take place in Cancun, Mexico from 1-4 May 2014. Up to 3000 delegates are expected to attend.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.
A team of researchers from the US and UK used the AGM intranasal model of SARS-CoV-2 infection to determine differences between a contemporary SARS-CoV-2 D614G variant circulating in summer 2020 and the B.1.1.7 UK variant of concern that emerged in late 2020.
› Verified 7 days ago
| Provider Name | Katherine Quinn Emery |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1790312684 PECOS PAC ID: 7618399783 Enrollment ID: I20230804000862 |
News Archive
It doesn't take a political genius to see where the contest between President Obama and Mitt Romney is heading. With Rep. Paul Ryan on the Republican ticket, the campaign is looking at a full-throated debate over the future of Medicare. Are Romney and Ryan ready?
The world's most important scientific congress on the menopause will take place in Cancun, Mexico from 1-4 May 2014. Up to 3000 delegates are expected to attend.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.
A team of researchers from the US and UK used the AGM intranasal model of SARS-CoV-2 infection to determine differences between a contemporary SARS-CoV-2 D614G variant circulating in summer 2020 and the B.1.1.7 UK variant of concern that emerged in late 2020.
› Verified 7 days ago
News Archive
It doesn't take a political genius to see where the contest between President Obama and Mitt Romney is heading. With Rep. Paul Ryan on the Republican ticket, the campaign is looking at a full-throated debate over the future of Medicare. Are Romney and Ryan ready?
The world's most important scientific congress on the menopause will take place in Cancun, Mexico from 1-4 May 2014. Up to 3000 delegates are expected to attend.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.
A team of researchers from the US and UK used the AGM intranasal model of SARS-CoV-2 infection to determine differences between a contemporary SARS-CoV-2 D614G variant circulating in summer 2020 and the B.1.1.7 UK variant of concern that emerged in late 2020.
› Verified 7 days ago
Dry Ridge Family Medicine Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 104 N Main St, Weaverville, NC 28787 Phone: 828-645-7974 Fax: 828-645-9798 | |
Mission Family Medical - Weaverville Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 63 Monticello Rd, Weaverville, NC 28787 Phone: 828-645-3066 Fax: 828-658-3944 | |
Ppadwvl Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3 N Main St, Weaverville, NC 28787 Phone: 828-713-9626 Fax: 828-484-8956 | |
Be Strong Wellness Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 214 N Main St, Weaverville, NC 28787 Phone: 919-621-2754 | |
Dula Springs Wellness Center Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6 Morningside Dr, Weaverville, NC 28787 Phone: 828-484-9032 | |
Weaverville Family Medicine Associates, Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 63 Monticello Rd, Weaverville, NC 28787 Phone: 828-645-3066 Fax: 828-658-1445 |